Cross-country evidence on the role of national governance in boosting COVID-19 vaccination
Abstract Background Frequent mutations of the COVID-19 virus, such as the Delta and Omicron variants, have prolonged the pandemic. Rich countries have approved the booster shots (3rd doses) of vaccine, but this causes further delay of vaccination in developing countries. This raises the risk of furt...
Saved in:
Main Authors: | Takeshi Aida (Author), Masahiro Shoji (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COVID-19 Vaccine Booster: To Boost or Not to Boost
by: Rahul Shekhar, et al.
Published: (2021) -
Heterologous Prime-boost COVID-19 Vaccination
by: Vishal R. Tandon, et al.
Published: (2021) -
Curcumin: Boosting the immunity of COVID-19-vaccinated populations
by: Sry Suryani Widjaja, et al.
Published: (2022) -
New vaccines to boost child care in developing countries
by: Jane Parry
Published: (2007) -
'Vaccinate my village' strategy in Malawi: an effort to boost COVID-19 vaccination
by: Ghanshyam Sethy, et al.
Published: (2023)